The feasibility of acceptance and commitment therapy (ACT) on psychological flexibility and psychological well-being among breast cancer patients with chronic pai
Not Applicable
Not yet recruiting
- Conditions
- Breast CancerChronic painCancer - BreastMental Health - Studies of normal psychology, cognitive function and behaviour
- Registration Number
- ACTRN12624000542594
- Lead Sponsor
- niversity of Cyberjaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
1. Participants must be able to read and write.
2. Participants diagnose with breast cancer (stage 2/3) or who are at least after 6 months post-diagnosis.
3. Participants who have been experiencing pain for more than 3 months.
4. Participants must be 18 years old and above.
Exclusion Criteria
1. Individuals who are formally diagnosed with mental disorders or are under psychotropic medication.
2. Patient unable to give consent, i.e. due to mental or disease issues (metastatic spread to the brain, etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie ACT's impact on psychological flexibility in breast cancer patients with chronic pain?
How does ACT compare to CBT in managing chronic pain and psychological well-being among breast cancer survivors?
Are there specific biomarkers that predict response to ACT in breast cancer-related chronic pain populations?
What adverse events are associated with ACT interventions in oncology settings and how are they managed?
What combination therapies show promise with ACT for improving mental health outcomes in metastatic breast cancer patients?